Who Paid My Doc
Arthur Edelstein
Optometrist, Vision Therapy Lynwood, CA Medical Doctor
NPI 1043256175 CMS profile 535296
3737 Martin Luther King Jr Blvd, #340, Lynwood, CA 90262
General payments
$30
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Arthur Edelstein of Lynwood, CA is reported in the CMS Open Payments database as having received $30 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 9th percentile of Optometrist, Vision Therapy profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $30 | 1 |
Beside peers
- Arthur Edelstein
- Optometrist, Vision Therapy median
- Middle half of Optometrist, Vision Therapy
- National median
In program year 2025, general payments to Arthur Edelstein were reported at $30. Among 159 Optometrist, Vision Therapy profiles paid that year, the median was $172 and the middle half received between $65 and $349.
Show as a table
| Year | Arthur Edelstein | Optometrist, Vision Therapy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $149 | $42–$361 | $163 |
| 2020 | $0 | $59 | $20–$146 | $114 |
| 2021 | $0 | $114 | $43–$217 | $132 |
| 2022 | $0 | $130 | $46–$350 | $149 |
| 2023 | $0 | $153 | $70–$363 | $160 |
| 2024 | $0 | $157 | $71–$362 | $164 |
| 2025 | $30 | $172 | $65–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 22 drugsPart D claims
4,185
Drug cost
$115,515
Branded share of claims
17.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Brimonidine Tartrate | Generic | 570 | $19,972 | |
| Lumigan Bimatoprost | Brand | 37 | $14,171 | |
| Latanoprost | Generic | 1,841 | $11,705 | |
| Rhopressa Netarsudil Mesylate | Brand | 14 | $10,448 | |
| Alphagan P Brimonidine Tartrate | Brand | 21 | $8,777 | |
| Brinzolamide | Generic | 71 | $8,660 | |
| Restasis Cyclosporine | Brand | 11 | $7,931 | |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | Brand | 463 | $6,488 | |
| Prednisolone Acetate | Generic | 153 | $6,065 | |
| Cyclosporine | Generic | 16 | $4,306 |
The 10 drugs with the highest cost, of 22 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,260 Part D prescribers listed as Ophthalmology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 26 billing codesPaid by Medicare
$76,010
Medicare patients
367
Services billed
960
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 66% | |
| Arthritis | 48% | |
| Chronic kidney disease | 42% | |
| Ischemic heart disease | 29% | |
| Heart failure | 28% | |
| Depression | 20% | |
| Osteoporosis | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Vision Therapy in California
Alan Winkelstein
Optometrist, Vision Therapy · Temecula, CA
Beth Ballinger
Optometrist, Vision Therapy · Newport Beach, CA
Gary Polan
Optometrist, Vision Therapy · Pacific Palisades, CA
Leanne Liddicoat
Optometrist, Vision Therapy · Roseville, CA
Elizabeth Yeh
Optometrist, Vision Therapy · Pacific Palisades, CA
Brenda Coen
Optometrist, Vision Therapy · Citrus Heights, CA
Related records
Optometrist, Vision Therapy in California
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Vision Therapy
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.